These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32315368)

  • 21. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
    Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
    Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Patel A; Panchal H; Dubinsky MC
    Inflamm Bowel Dis; 2017 Sep; 23(9):1600-1604. PubMed ID: 28590341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
    Jusué V; Chaparro M; Gisbert JP
    Dig Liver Dis; 2018 Apr; 50(4):353-359. PubMed ID: 29396129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Method of diagnosis of the severity of the disease attack in patients with ulcerative colitis.].
    Tretyakova YI; Bulatova IA; Shchekotova AP; Sheludko VS
    Klin Lab Diagn; 2018; 63(7):414-418. PubMed ID: 30720956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis.
    Lobatón T; Rodríguez-Moranta F; Lopez A; Sánchez E; Rodríguez-Alonso L; Guardiola J
    Inflamm Bowel Dis; 2013 Apr; 19(5):1034-42. PubMed ID: 23470502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.
    Yamaguchi S; Takeuchi Y; Arai K; Fukuda K; Kuroki Y; Asonuma K; Takahashi H; Saruta M; Yoshida H
    J Gastroenterol Hepatol; 2016 Jan; 31(1):93-8. PubMed ID: 26212346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
    Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe Disease.
    Kedia S; Jain S; Goyal S; Bopanna S; Yadav DP; Sachdev V; Sahni P; Pal S; Dash NR; Makharia G; Travis SPL; Ahuja V
    Dig Dis Sci; 2018 Oct; 63(10):2747-2753. PubMed ID: 29948556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.
    Fukunaga S; Kuwaki K; Mitsuyama K; Takedatsu H; Yoshioka S; Yamasaki H; Yamauchi R; Mori A; Kakuma T; Tsuruta O; Torimura T
    Int J Mol Med; 2018 Jan; 41(1):107-118. PubMed ID: 29115397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E-major Urinary Metabolite as a Biomarker for Pediatric Ulcerative Colitis Activity.
    Hagiwara SI; Okayasu I; Fujiwara M; Matsuura M; Ohnishi H; Ito S; Kishimoto H; Nambu R; Kagimoto S
    J Pediatr Gastroenterol Nutr; 2017 Jun; 64(6):955-961. PubMed ID: 27906804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum neutrophil gelatinase-associated lipocalin (NGAL) correlates with clinical and endoscopic activity in ulcerative colitis but fails to predict activity in Crohn's disease.
    Budzynska A; Gawron-Kiszka M; Nowakowska-Dulawa E; Spiewak J; Lesinska M; Kukla M; Waluga M; Hartleb M
    J Physiol Pharmacol; 2017 Dec; 68(6):859-865. PubMed ID: 29550798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Renzulli P; Seibold F
    Inflamm Bowel Dis; 2009 Dec; 15(12):1851-8. PubMed ID: 19462421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity.
    Cherfane CE; Gessel L; Cirillo D; Zimmerman MB; Polyak S
    Inflamm Bowel Dis; 2015 Aug; 21(8):1769-75. PubMed ID: 25993688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlations of C-reactive protein levels and erythrocyte sedimentation rates with endoscopic activity indices in patients with ulcerative colitis.
    Yoon JY; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Dis Sci; 2014 Apr; 59(4):829-37. PubMed ID: 24352705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trefoil Factor 3 is Highly Predictive of Complete Mucosal Healing Independently and in Combination with C-Reactive Protein in Patients with Ulcerative Colitis.
    Nakov R; Velikova T; Nakov V; Gerova V; Tankova L
    J Gastrointestin Liver Dis; 2019 Jun; 28():169-174. PubMed ID: 31204414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis.
    Hassan EA; Ramadan HK; Ismael AA; Mohamed KF; El-Attar MM; Alhelali I
    Saudi J Gastroenterol; 2017; 23(4):238-245. PubMed ID: 28721978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Improved Mayo Endoscopic Score has a higher value for evaluating clinical severity of ulcerative colitis].
    Song Z; Zhang M; Ren Y; Iang B
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):997-1005. PubMed ID: 35869761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.